跳至主要内容
临床试验/NL-OMON29079
NL-OMON29079已完成不适用

Tumor Necrosis Factor blockade in patients with Rheumatoid Arthritis inhibits Atherothrombosis.

Academic Medical CenterAmsterdam, the Netherlands0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or female patients who were priorly diagnosed with RA, who are currently experiencing an inflammatory episode and who will be treated with TNF-alpha blockade;
  • 2. Age 18-80 years.

排除标准

  • 1. Patients who were priorly diagnosed with diabetes, hypertension or cardiovascular disease;
  • 2. Current signs or symptoms of severe, progressive or uncontrolled hepatic, haematological, gastroenterological, endocrine, pulmonary, cardiac or neurological disease.

研究者

发起方
Academic Medical CenterAmsterdam, the Netherlands

相似试验